Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$63.15 - $72.88 $9,409 - $10,859
-149 Reduced 4.66%
3,050 $209,000
Q1 2024

Apr 22, 2024

BUY
$71.58 - $87.29 $9,520 - $11,609
133 Added 4.34%
3,199 $234,000
Q4 2023

Jan 26, 2024

BUY
$73.27 - $83.09 $3,150 - $3,572
43 Added 1.42%
3,066 $248,000
Q3 2023

Nov 07, 2023

BUY
$73.94 - $80.67 $4,288 - $4,678
58 Added 1.96%
3,023 $226,000
Q2 2023

Aug 02, 2023

BUY
$76.01 - $86.7 $304 - $346
4 Added 0.14%
2,965 $228,000
Q1 2023

Apr 21, 2023

BUY
$77.31 - $88.08 $309 - $352
4 Added 0.14%
2,961 $245,000
Q4 2022

Feb 03, 2023

BUY
$62.32 - $89.47 $184,280 - $264,562
2,957 New
2,957 $253,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $111B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Eagle Strategies LLC Portfolio

Follow Eagle Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Strategies LLC with notifications on news.